Safety, Tolerability and Efficacy of Adjunctive TBO-309 in Reperfusion for Stroke With Tandem Occlusion
Clinical trial NCT06813651 · RECRUITING
Trial details
- NCT number
- NCT06813651
- Sponsor
- ThromBio Pty. Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-04
- Primary completion
- 2026-12-30
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.